Search research articles
Contact Us
Filters
Showing results (1-10 of 242) with videos related to
Page
of 25
Sort By:
Oncology Research and Treatment
|
June 6, 2015
Updated Evidence on the Mechanisms of Resistance to ALK Inhibitors and Strategies to Overcome Such Resistance: Clinical and Preclinical Data
Gouji Toyokawa, Takashi Seto
Current Treatment Options in Oncology
|
October 16, 2015
The Role of Radiotherapy in the Treatment of Small-Cell Lung Cancer
Kaname Nosaki, Takashi Seto
Clinical Lung Cancer
|
December 4, 2020
NTRK Fusion-positive Non-small-cell Lung Cancer: The Diagnosis and Targeted Therapy
Naoki Haratake, Takashi Seto
Clinical Lung Cancer
|
July 3, 2014
ALK inhibitors: what is the best way to treat patients with ALK+ non-small-cell lung cancer?
Gouji Toyokawa, Takashi Seto
Respiratory Investigation
|
December 3, 2014
Anaplastic lymphoma kinase rearrangement in lung cancer: its biological and clinical significance
Gouji Toyokawa, Takashi Seto
Expert Review of Anticancer Therapy
|
December 22, 2018
ALK testing methods: is there a winner or loser?
Yuka Kozuma, Gouji Toyokawa, Takashi Seto
Cancer Metastasis Reviews
|
September 7, 2015
Insights into brain metastasis in patients with ALK+ lung cancer: is the brain truly a sanctuary?
Gouji Toyokawa, Takashi Seto, Mitsuhiro Takenoyama, et al.
JTO Clinical and Research Reports
|
September 30, 2021
Optimizing Sequential Treatment With EGFR Tyrosine Kinase Inhibitor With a Simulation of the T790M Mutation Rate in <i>EGFR</i>-Mutated Lung Cancer
Naoki Haratake, Toshihiro Misumi, Takeharu Yamanaka, et al.
Clinical Lung Cancer
|
November 21, 2016
W'ALK' Into the Next Stage
Gouji Toyokawa, Takashi Seto, Mitsuhiro Takenoyama, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
January 15, 2016
Are Anthracycline-Based Regimens Truly Indicated To Be the Standard Chemotherapy Regimen for Thymic Carcinoma?
Fumihiko Hirai, Ryo Toyozawa, Kaname Nosaki, et al.
Page
of 25
Search research articles
Search
Showing results (1-10 of 242) with videos related to
Sort By:
Page
of 25
Oncology Research and Treatment
|
June 6, 2015
Updated Evidence on the Mechanisms of Resistance to ALK Inhibitors and Strategies to Overcome Such Resistance: Clinical and Preclinical Data
Gouji Toyokawa, Takashi Seto
Current Treatment Options in Oncology
|
October 16, 2015
The Role of Radiotherapy in the Treatment of Small-Cell Lung Cancer
Kaname Nosaki, Takashi Seto
Clinical Lung Cancer
|
December 4, 2020
NTRK Fusion-positive Non-small-cell Lung Cancer: The Diagnosis and Targeted Therapy
Naoki Haratake, Takashi Seto
Clinical Lung Cancer
|
July 3, 2014
ALK inhibitors: what is the best way to treat patients with ALK+ non-small-cell lung cancer?
Gouji Toyokawa, Takashi Seto
Respiratory Investigation
|
December 3, 2014
Anaplastic lymphoma kinase rearrangement in lung cancer: its biological and clinical significance
Gouji Toyokawa, Takashi Seto
Expert Review of Anticancer Therapy
|
December 22, 2018
ALK testing methods: is there a winner or loser?
Yuka Kozuma, Gouji Toyokawa, Takashi Seto
Cancer Metastasis Reviews
|
September 7, 2015
Insights into brain metastasis in patients with ALK+ lung cancer: is the brain truly a sanctuary?
Gouji Toyokawa, Takashi Seto, Mitsuhiro Takenoyama, et al.
JTO Clinical and Research Reports
|
September 30, 2021
Optimizing Sequential Treatment With EGFR Tyrosine Kinase Inhibitor With a Simulation of the T790M Mutation Rate in <i>EGFR</i>-Mutated Lung Cancer
Naoki Haratake, Toshihiro Misumi, Takeharu Yamanaka, et al.
Clinical Lung Cancer
|
November 21, 2016
W'ALK' Into the Next Stage
Gouji Toyokawa, Takashi Seto, Mitsuhiro Takenoyama, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
January 15, 2016
Are Anthracycline-Based Regimens Truly Indicated To Be the Standard Chemotherapy Regimen for Thymic Carcinoma?
Fumihiko Hirai, Ryo Toyozawa, Kaname Nosaki, et al.
Page
of 25